These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3804459)

  • 21. Further characterization of IgE-binding antigens in kiwi, with particular emphasis on glycoprotein allergens.
    Fahlbusch B; Rudeschko O; Schumann C; Steurich F; Henzgen M; Schlenvoigt G; Jäger L
    J Investig Allergol Clin Immunol; 1998; 8(6):325-32. PubMed ID: 10028478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A RAST neutralization test for detection of blocking antibodies in serum after hyposensitization.
    Wide L
    Int Arch Allergy Appl Immunol; 1976; 52(1-4):219-26. PubMed ID: 797667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specificities of IgE and IgG antibodies in patients with birch pollen allergy.
    Jarolim E; Rumpold H; Endler AT; Schlerka G; Ebner H; Scheiner O; Kraft D
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):180-2. PubMed ID: 2707881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
    Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
    Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of a human IgG4 antibody, BAB2, with specificity for the major Birch pollen allergen, Bet v 1 in Escherichia coli: recombinant BAB2 Fabs enhance the allergic reaction.
    Eibensteiner P; Denépoux S; Steinberger P; Kraft D; Visco V; Banchereau J; Lebecque S; Valenta R
    Int Arch Allergy Immunol; 1999; 118(2-4):190-2. PubMed ID: 10224374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination for birch pollen allergy: comparison of the affinities of specific immunoglobulins E, G1 and G4 measured by surface plasmon resonance.
    Jakobsen CG; Bodtger U; Poulsen LK; Roggen EL
    Clin Exp Allergy; 2005 Feb; 35(2):193-8. PubMed ID: 15725191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific IgG antibodies (total and subclasses) against Saffron pollen: a study of their correlation with specific IgE and immediate skin reactions.
    Varasteh AR; Vahedi F; Sankian M; Kaghazian H; Tavallaie S; Abolhassani A; Kermani T; Mahmoudi M
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):189-95. PubMed ID: 18094441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of IgE antibodies in mice and rhesus monkeys with recombinant birch pollen allergens: different allergenicity of Bet v 1 and Bet v 2.
    Vrtala S; Mayer P; Ferreira F; Susani M; Sehon AH; Kraft D; Valenta R
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):913-21. PubMed ID: 8939154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
    Vrtala S; Akdis CA; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
    J Immunol; 2000 Dec; 165(11):6653-9. PubMed ID: 11086111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific hyposensitization in patients allergic to Parietaria officinalis pollen allergen.
    Cvitanović S; Zekan L; Capkun V; Marusić M
    J Investig Allergol Clin Immunol; 1994; 4(6):283-90. PubMed ID: 7735515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal IgE antibodies against birch pollen allergens: novel tools for biological characterization and standardization of allergens.
    Kaul S; Scheurer S; Danz N; Schicktanz S; Vieths S; Hoffmann A
    J Allergy Clin Immunol; 2003 Jun; 111(6):1262-8. PubMed ID: 12789227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Default" versus "pre-atopic" IgG responses to foodborne and airborne pathogenesis-related group 10 protein molecules in birch-sensitized and nonatopic children.
    Hofmaier S; Hatzler L; Rohrbach A; Panetta V; Hakimeh D; Bauer CP; Hoffman U; Forster J; Zepp F; Schuster A; Stock P; Wahn U; Keil T; Lau S; Matricardi PM
    J Allergy Clin Immunol; 2015 May; 135(5):1367-74.e1-8. PubMed ID: 25458000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of bacterial immunomodulators on the induction of specific IGG with patients during a peroral hyposensitization therapy.
    Hradilová S
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2001 Sep; 145(1):11-4. PubMed ID: 12415636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of the potency of pollen extract by radioimmunoprecipitation.
    Leiferman KM; Yunginger JW; Gleich GJ
    J Allergy Clin Immunol; 1979 Sep; 64(3):173-81. PubMed ID: 469117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
    Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
    J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoblotting in the diagnosis of cross-reactivity in children allergic to birch.
    Cudowska B; Kaczmarski M; Restani P
    Rocz Akad Med Bialymst; 2005; 50():268-73. PubMed ID: 16358981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.
    Ferreira F; Hirtenlehner K; Jilek A; Godnik-Cvar J; Breiteneder H; Grimm R; Hoffmann-Sommergruber K; Scheiner O; Kraft D; Breitenbach M; Rheinberger HJ; Ebner C
    J Exp Med; 1996 Feb; 183(2):599-609. PubMed ID: 8627171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characterization of polygalacturonases as grass pollen-specific marker allergens: expulsion from pollen via submicronic respirable particles.
    Swoboda I; Grote M; Verdino P; Keller W; Singh MB; De Weerd N; Sperr WR; Valent P; Balic N; Reichelt R; Suck R; Fiebig H; Valenta R; Spitzauer S
    J Immunol; 2004 May; 172(10):6490-500. PubMed ID: 15128842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: a quantitative IgE inhibition study with sera from different populations.
    Niederberger V; Pauli G; Grönlund H; Fröschl R; Rumpold H; Kraft D; Valenta R; Spitzauer S
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):579-91. PubMed ID: 9802365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of specific IgE antibodies in sera of Japanese birch-allergic patients using recombinant allergens Bet v 1, Bet v 2 and Bet v 4.
    Shirasaki H; Yamamoto T; Koyanagi Y; Watanabe N; Himi T
    Allergol Int; 2008 Mar; 57(1):93-6. PubMed ID: 18209509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.